The Better, Harder, Faster, Stronger Study

Part of paid clinical trials in Winston-Salem, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT07220512
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
55 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • data collection — OTHER
    PROs, historical and longitudinal data collection and eFI calculation

Study Details

The purpose of this study is to evaluate changes in the electronic Frailty Index (eFI) score following 3-4 cycles of neoadjuvant chemotherapy (NACT) in participants with advanced ovarian and endometrial cancer.

Key Dates

Start date
Jul 28, 2025
Status verified
Oct 2025
Primary completion
Nov 30, 2026
Completion
May 31, 2027

Study Design

Enrollment
35 participants (estimated)

Arms

  • Arm: Participants with ovarian or endometrial carcinoma with planned NACT.
    Participants over 55 years old with either ovarian/primary peritoneal/fallopian tube carcinoma or endometrial carcinoma

Primary Outcome Measure

Change in electronic frailty index (eFI) [ Time Frame: From pre- Neoadjuvant Chemotherapy (NACT; no later than 60 days after consent) to post-NACT (no later than 30 days after completion of the last cycle of NACT) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Wake Forest Baptist Comprehensive Cancer CenterWinston-SalemNorth Carolina27157
Sydney McEntire, RN
[email protected]
336-713-5879
Anna Kuan-Celarier, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Winston-Salem, NC

By condition
Endometrial cancerOvarian cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Wake Forest Baptist Comprehensive Cancer Center· Winston-Salem, NC

Related Studies